| |
| |
|
| Insider
Information: |
Rothblatt Martine A |
| Relationship: |
|
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
130 |
|
|
Indirect Shares
|
647,065 |
|
|
| Direct
Value |
$34,804 |
|
|
|
Indirect Value
|
$173,232,242 |
|
|
| Total
Shares |
647,195 |
|
|
| Total
Value |
$173,267,045 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
United Therapeutics Corp |
UTHR |
|
2024-05-24 |
130 |
2024-05-24 |
647,065 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
2042 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 47 of 82
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| UTHR |
United Therapeutics Corp |
Chairman & Co-CEO |
• • – |
2016-03-17 |
4 |
AS |
$117.64 |
$655,769 |
D/D |
(5,547) |
240 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & Co-CEO |
• • – |
2016-03-31 |
4 |
OE |
$30.75 |
$170,570 |
D/D |
5,547 |
5,787 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & Co-CEO |
• • – |
2016-03-31 |
4 |
AS |
$111.11 |
$619,643 |
D/D |
(5,547) |
240 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & Co-CEO |
• • – |
2016-04-14 |
4 |
OE |
$30.75 |
$170,570 |
D/D |
5,547 |
5,787 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & Co-CEO |
• • – |
2016-04-14 |
4 |
AS |
$113.97 |
$634,116 |
D/D |
(5,547) |
240 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & Co-CEO |
• • – |
2016-04-28 |
4 |
OE |
$30.75 |
$170,570 |
D/D |
5,547 |
5,787 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & Co-CEO |
• • – |
2016-04-28 |
4 |
AS |
$103.47 |
$592,499 |
D/D |
(5,547) |
240 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & Co-CEO |
• • – |
2016-05-12 |
4 |
OE |
$30.75 |
$170,570 |
D/D |
5,547 |
5,787 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & Co-CEO |
• • – |
2016-05-12 |
4 |
AS |
$108.66 |
$604,746 |
D/D |
(5,547) |
240 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & Co-CEO |
• • – |
2016-05-26 |
4 |
OE |
$30.75 |
$170,570 |
D/D |
5,547 |
5,787 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & Co-CEO |
• • – |
2016-05-26 |
4 |
AS |
$117.47 |
$652,146 |
D/D |
(5,547) |
240 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & Co-CEO |
• • – |
2015-11-27 |
4 |
OE |
$30.75 |
$171,058 |
D/D |
5,561 |
255 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Chairman & Co-CEO |
• • – |
2015-11-27 |
4 |
AS |
$152.76 |
$855,340 |
D/D |
(5,561) |
240 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2011-12-20 |
4 |
B |
$44.46 |
$249,620 |
I/I |
5,615 |
656,095 |
2.66 |
- |
|
| UTHR |
United Therapeutics Corp |
|
– • – |
2024-05-20 |
4 |
AS |
$273.24 |
$1,574,825 |
D/D |
(5,732) |
696 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2013-12-23 |
4 |
AS |
$104.00 |
$630,041 |
I/I |
(5,743) |
630,333 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2013-12-23 |
4 |
AS |
$106.11 |
$650,123 |
I/I |
(5,898) |
636,076 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2011-12-19 |
4 |
B |
$43.43 |
$269,591 |
I/I |
6,208 |
650,480 |
2.66 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2011-12-16 |
4 |
AB |
$42.85 |
$269,586 |
I/I |
6,291 |
644,272 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CHAIRPERSON & CEO |
• • – |
2024-03-05 |
4 |
OE |
$129.49 |
$815,787 |
D/D |
6,300 |
6,430 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CHAIRPERSON & CEO |
• • – |
2024-03-05 |
4 |
AS |
$230.36 |
$1,454,886 |
D/D |
(6,300) |
130 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
CHAIRPERSON & CEO |
• • – |
2022-12-14 |
4 |
AS |
$275.53 |
$1,746,262 |
D/D |
(6,310) |
130 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2011-12-06 |
4 |
AB |
$42.32 |
$269,593 |
I/I |
6,370 |
592,756 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2011-12-09 |
4 |
AB |
$42.24 |
$269,327 |
I/I |
6,375 |
612,125 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
CEO |
• • – |
2011-12-05 |
4 |
AB |
$42.15 |
$268,915 |
I/I |
6,380 |
586,386 |
0 |
- |
|
2042 Records found
|
|
Page 47 of 82 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
